KTOV: Buy the Rumor; Sell the News

Kitov Pharma is a clinical-stage company focusing on advancing first in class therapies to overcome tumor immune evasion and drug resistance , to create successful long lasting treatment for people with cancer.

Word on the street is there is might be a possible buy out to by Merck & Co (MRK)

MRK filed an 8K SEC filing

Limited information on what the 8K SEC filing was for

Just got a approved for NT-219 drug

Estimated to be Worth close to a billion

Closed direct offering for 35.0 Million

Lots of momentum from 06/24/20 - may continue into Monday

This is not stock advice to buy, do your own dd